Form 15-12B Intersect ENT, Inc.
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File No. 001-36545
Intersect ENT, Inc.
(Exact name of registrant as specified in its charter)
1555 Adams Drive
Menlo Park, California 94025
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Stock, par value $0.01 per share
(Title of each class of securities covered by this Form)
(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Approximate number of holders of record as of the certification or notice date: One.
Pursuant to the requirements of the Securities Exchange Act of 1934, Intersect ENT, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|Intersect ENT, Inc.|
|Date: May 23, 2022||By:|
|Senior VP, Corporate Development|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Frontdoor Extends Support for the National SkillsUSA Leadership and Skills Conference
- TechTarget's SearchVMware.com Announces Call for Nominations of Best of VMware Explore 2022 Awards
- Trip.com Group Limited Reports Unaudited First Quarter of 2022 Financial Results
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!